Hepatobiliary cancer encompasses a spectrum of malignant tumors arising in the liver, bile ducts, and gallbladder. These cancers are increasingly identified worldwide, posing a significant clinical challenge. Contributing variables for hepatobiliary cancer comprise hepatitis infection, cirrhosis, diabetes, and habitual alcohol consumption. Early de